Alnylam Pharmaceuticals, Inc. (ALNY) vs BioNTech SE Sponsored ADR (BNTX)
- Alnylam Pharmaceuticals, Inc. ALNY 231.83 −0.94%
- BioNTech SE Sponsored ADR BNTX 87.57 −2.92%
Alnylam Pharmaceuticals, Inc. and BioNTech SE Sponsored ADR are both Biotechnology companies. Alnylam Pharmaceuticals, Inc. is the larger, with a market value of $31.3B against $22.7B — 1.4× the size. BioNTech SE Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Alnylam Pharmaceuticals, Inc. trades at 39.5×. Alnylam Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 95.1% against −3.33%. Alnylam Pharmaceuticals, Inc. has the higher net margin (16.1% vs −65.8%) and the higher return on invested capital (0.00% vs −38.4%). Across the 19 metrics below, Alnylam Pharmaceuticals, Inc. leads on 15 and BioNTech SE Sponsored ADR on 4.
Valuation
Profitability
| Metric | ALNY | BNTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 79.65% | 75.24% | 65.16% |
| Operating margin | 20.81% | (77.94%) | 0.00% |
| Net margin | 16.13% | (65.75%) | 0.00% |
| Free cash flow margin | 17.07% | 16.58% | 0.00% |
| Return on equity | 96.55% | (9.53%) | (56.36%) |
| Return on assets | 15.30% | (8.24%) | (48.04%) |
| Return on invested capital | 0.00% | (38.39%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack